Key Dates
Deadline for proposal submission: 19 Aug 2024
Communication to selected speakers by ISCR 31 Oct 2024
Deadline for submitting final presentations (PPTs) / panel content: 10 Dec 2024
If you have any questions about the Call for Proposals, please contact ISCR at
info@iscr.org, with Subject line: ISCR Annual Conference 2025: Call for Proposals ISCR reserves the right to accept or reject any proposals without providing any reasons for the same.
As a member-driven organization, we encourage proposal submitters to be ISCR members. If you are not a current ISCR member, you can apply for or renew your membership at https://www.iscr.org/Member_Registration.aspx
Selection Process
The selected proposals will ensure that the conference offers a comprehensive and non-promotional scientific program that meets the objectives and guiding principles of ISCR. Proposals that clearly describe innovative and cutting-edge work in the field of clinical research and are around the theme of the conference will receive the highest priority in the selection process. Previously presented and published abstracts must be properly acknowledged by providing the citation to that abstract.
Proposals will be reviewed by the Scientific Organizing Committee and other reviewers in a double-blinded and unbiased way using the following criteria:
Thank you for considering our invitation, and we eagerly anticipate receiving your compelling session proposals.
-
Topic : Relevance, Importance, Value, and/or Interest to Clinical Research Community
-
Quality of Submission : Quality, Content, Clarity, and Depth of Demonstrated Understanding of the Topic
-
Aligned to the Conference Theme : Content Aligns to the Overall Conference Theme
Some examples of suggested topic/session themes
Clinical Development, Operations & Regulatory Affairs
- Patients as partners in research
- Patient-focused drug development - Guidance from regulatory authorities
- Confidence in clinical research - Understanding regulations, guidelines, practices & real-world applications, data integrity, analysis & communications, & advocacy
- Driving diversity & equity in clinical trials
- Impact of the pandemic on clinical research scenario in India
- Evolution of clinical research in India post pandemic
- Monitoring - what has changed since the pandemic
- Inspection readiness
HEOR & RWE
- Using RWE in healthcare decision making
- RWD & RWE in supporting clinical trial designs
- Leveraging AI in analyzing RWE
- Can RWE replace clinical trials – a panel discussion
Biostatistics & Statistical Programming
- Modeling & simulation methodology in drug development
- Protocol designs & optimization of protocol design
- Bayesian approaches in clinical trials
- Re-identification risk assessment - Role of biostatisticians
- Risk-based approach in clinical trials (RBM/RBQM)
- Pediatric Covid-19 studies - Statistical issues in a pandemic
Medical Writing
- Medical writing in the era of artificial intelligence
- Digital technologies in publications
- Optimizing journal submission process
- Structured authoring; TransCelerate e-Templates
- NDA/MAA/BLA submission optimization
- FDA Assessment Aids
- Types of eCTD submission packages: differences & similarities
- Innovations in readying documents for submission
Clinical Data Management
- eSource initiative for more efficient data collection practices
- The growing importance of synthetic data
- Clinical data management in RWE studies
- Data protection policies - Impact on data management practices
Pharmacovigilance & Safety
- Lessons in PV - Experiences with COVID-19 vaccines
- Reference safety information: What does EU CTR change?
- Aggregate safety assessments
- Estimands in safety & benefit-risk evaluation